[Effect of muramyl dipeptide on proliferation of dendritic cells derived from children acute leukemia bone marrow in vitro]
- PMID: 20723309
[Effect of muramyl dipeptide on proliferation of dendritic cells derived from children acute leukemia bone marrow in vitro]
Abstract
The aim of this study was to explore the effect of muramyl dipeptide (MDP) on proliferation of dendritic cells (DCs) from bone marrow of children with acute leukemia in vitro. The mononuclear cells were isolated from bone marrow of children with acute leukemia to induce dendritic cells. The experiment was divided into 4 groups. The control group: MNC + RPMI 1640 medium; test group 1: MNC + MDP; test group 2: MNC + rhGM-CSF + IL-4 + rhTNFα; test group 3: MNC + rhGM-CSF + IL-4 + rhTNFα + MDP. The growth of DCs was observed by inverted microscope every day; the number of DCs in different groups were counted, the immunophenotypes of DCs were detected by flow cytometry on day 8 of culture. The results indicated that a certain number of typical DCs could be detected in all experimental groups. The DC number in control and 3 test groups were (0.85 ± 0.23) x 10⁵/L, (2.31 ± 0.24) x 10⁵/L, (3.26 ± 0.37) x 10⁵/L and (4.16 ± 0.34) x 10⁵/L, respectively, among which DC number is in all 3 test groups were higher than that in control group (p < 0.01), the DC number in test group 1 was lower than that in test groups 2 and 3 (p < 0.01), while it in test group 3 was higher than that in test group 2 (p < 0.01). The percentages of HLA-DR in control, test group 1, 2 and 3 were 19.98 ± 3.74, 37.24 ± 4.32, 58.81 ± 2.08 and 77.48 ± 5.57 respectively; the percentages of CD1a and CD83 in control, test group 1, 2 and 3 were 11.46 ± 2.43, 28.71 ± 6.64, 46.92 ± 4.78 and 57.03 ± 3.07, as well as 13.05 ± 5.70, 36.32 ± 5.61, 54.95 ± 7.83 and 75.70 ± 6.67 respectively. The comparison of HLA-DR, CD1a and CD83 levels in control and test group 1, 2 showed that their results were consistent with results of DC numbers. It is concluded that MDP not only promotes the proliferation of DCs derived from bone marrow of children with acute leukemia in vitro, cooperates with rhGM-CSF, rhIL-4 and rhTNFalpha in promoting of the proliferation and maturation of DCs, while the promotive effect of MDP alone on the proliferation of DCs is not as good as its combination with cytokines.
Similar articles
-
[Influence of crocin on proliferation in vitro and function of dendritic cells derived from bone marrow of children with acute leukemia].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Feb;20(1):57-61. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012. PMID: 22391165 Chinese.
-
[Anti-leukemia activity of T cells impacted by dendritic cells added with sodium selenite].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):892-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18718085 Chinese.
-
[Effect of Bacillus Calmette-Guerin on the expansion of dendritic cells from peripheral blood of pediatric patients with leukemia in vitro].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Oct;18(5):1240-3. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010. PMID: 21129268 Chinese.
-
Muramyl Dipeptide modulates differentiation, maturity of dendritic cells and anti-tumor effect of DC-mediated T cell in acute leukemia children.Hum Vaccin. 2011 Jun;7(6):618-24. doi: 10.4161/hv.7.6.14988. Epub 2011 Jun 1. Hum Vaccin. 2011. PMID: 21445005
-
[Effects of ST1571 on the development of dendritic cells derived from bone marrow mononuclear cells in patients with chronic myeloid leukemia].Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):920-3. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17533744 Chinese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials